Hypertension, often termed the “silent killer,” remains a leading risk factor for cardiovascular morbidity and mortality worldwide. While pharmacological therapy plays a central role in its management, growing evidence supports the adjunctive role of dietary factors—particularly Vitamin C—in blood pressure regulation. This essential water-soluble vitamin, widely known for its antioxidant properties, has demonstrated promising effects in reducing both systolic and diastolic blood pressure.
Vitamin C (ascorbic acid) contributes to vascular health primarily through its potent antioxidant action. Oxidative stress plays a key role in the pathogenesis of hypertension by impairing endothelial function. The endothelium regulates vascular tone by releasing nitric oxide (NO), a vasodilator. Reactive oxygen species (ROS) degrade NO, leading to vasoconstriction and increased peripheral resistance. Vitamin C scavenges these free radicals, thereby preserving NO bioavailability and promoting vasodilation, ultimately lowering blood pressure.
Another mechanism involves the improvement of endothelial function. Vitamin C enhances endothelial nitric oxide synthase (eNOS) activity, increasing NO production. This results in improved arterial compliance and reduced vascular stiffness—two important determinants of blood pressure. Additionally, Vitamin C may reduce inflammation within the vascular wall, further contributing to improved vascular tone.
Vitamin C also influences the renin-angiotensin-aldosterone system (RAAS), which plays a central role in blood pressure regulation. Some studies suggest that Vitamin C may inhibit angiotensin-converting enzyme (ACE) activity, thereby reducing the production of angiotensin II, a potent vasoconstrictor. This effect is somewhat analogous to ACE inhibitor drugs, though less potent.
Clinical evidence supports these physiological mechanisms. A meta-analysis of randomized controlled trials by Juraschek et al. (2012) found that Vitamin C supplementation reduced systolic blood pressure by approximately 3.8 mmHg and diastolic blood pressure by about 1.5 mmHg. While these reductions may appear modest, even small decreases at the population level can significantly reduce the risk of stroke and coronary heart disease.
The benefits of Vitamin C appear more pronounced in individuals with existing hypertension compared to normotensive individuals. This suggests its potential as an adjunct therapy rather than a standalone treatment. Dietary sources of Vitamin C—such as citrus fruits, guava, strawberries, bell peppers, and green leafy vegetables—are preferred over supplements due to their additional nutritional benefits and lower risk of excessive intake.
However, it is important to note that high-dose supplementation may have adverse effects, including gastrointestinal discomfort and increased risk of kidney stones in susceptible individuals. Therefore, Vitamin C should be consumed within recommended dietary allowances unless prescribed otherwise.
In conclusion, Vitamin C plays a supportive role in reducing blood pressure through antioxidant effects, enhancement of endothelial function, and modulation of vasoregulatory systems. While it should not replace standard antihypertensive therapy, incorporating Vitamin C-rich foods into the diet represents a simple, cost-effective strategy to aid in blood pressure control and improve cardiovascular health.
References
- Juraschek SP, Guallar E, Appel LJ, Miller ER. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;95(5):1079–1088.
- Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999;69(6):1086–1107.
- Block G, Jensen CD, Dalvi TB, et al. Vitamin C treatment reduces elevated C-reactive protein. Free Radic Biol Med. 2009;46(1):70–77.
- Rodrigo R, Prat H, Passalacqua W, et al. Relationship between oxidative stress and essential hypertension. Hypertens Res. 2007;30(12):1159–1167.
- Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet. 1999;354(9195):2048–2049.